Scibase Ab Stock Net Income
| SCIB Stock | SEK 0.27 0.01 3.57% |
As of the 12th of February 2026, Scibase AB has the Semi Deviation of 5.52, risk adjusted performance of 0.0513, and Coefficient Of Variation of 1913.34. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scibase AB, as well as the relationship between them.
Analyzing historical trends in various income statement and balance sheet accounts from Scibase AB's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Scibase AB's valuation are summarized below:Scibase AB does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Scibase |
Scibase AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scibase AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scibase AB.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Scibase AB on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Scibase AB or generate 0.0% return on investment in Scibase AB over 90 days. Scibase AB is related to or competes with Real Heart, Iconovo, Arcoma AB, Biovica International, Immunovia Publ, Luxbright, and Nanologica. SciBase Holding AB , a medical technology company, develops and sells skin cancer diagnostic instruments in Europe and i... More
Scibase AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scibase AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scibase AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.55 | |||
| Information Ratio | 0.0411 | |||
| Maximum Drawdown | 51.44 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 9.52 |
Scibase AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scibase AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scibase AB's standard deviation. In reality, there are many statistical measures that can use Scibase AB historical prices to predict the future Scibase AB's volatility.| Risk Adjusted Performance | 0.0513 | |||
| Jensen Alpha | 0.2862 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0392 | |||
| Treynor Ratio | 0.3228 |
Scibase AB February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0513 | |||
| Market Risk Adjusted Performance | 0.3328 | |||
| Mean Deviation | 4.81 | |||
| Semi Deviation | 5.52 | |||
| Downside Deviation | 7.55 | |||
| Coefficient Of Variation | 1913.34 | |||
| Standard Deviation | 7.2 | |||
| Variance | 51.9 | |||
| Information Ratio | 0.0411 | |||
| Jensen Alpha | 0.2862 | |||
| Total Risk Alpha | (0.26) | |||
| Sortino Ratio | 0.0392 | |||
| Treynor Ratio | 0.3228 | |||
| Maximum Drawdown | 51.44 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 9.52 | |||
| Downside Variance | 57.01 | |||
| Semi Variance | 30.43 | |||
| Expected Short fall | (7.14) | |||
| Skewness | 1.07 | |||
| Kurtosis | 6.07 |
Scibase AB Backtested Returns
Scibase AB appears to be out of control, given 3 months investment horizon. Scibase AB owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0523, which indicates the firm had a 0.0523 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Scibase AB, which you can use to evaluate the volatility of the company. Please review Scibase AB's Coefficient Of Variation of 1913.34, risk adjusted performance of 0.0513, and Semi Deviation of 5.52 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Scibase AB holds a performance score of 4. The entity has a beta of 1.14, which indicates a somewhat significant risk relative to the market. Scibase AB returns are very sensitive to returns on the market. As the market goes up or down, Scibase AB is expected to follow. Please check Scibase AB's information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether Scibase AB's existing price patterns will revert.
Auto-correlation | -0.48 |
Modest reverse predictability
Scibase AB has modest reverse predictability. Overlapping area represents the amount of predictability between Scibase AB time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scibase AB price movement. The serial correlation of -0.48 indicates that about 48.0% of current Scibase AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.48 | |
| Spearman Rank Test | 0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Scibase AB reported net income of (41.78 Million). This is 112.24% lower than that of the Healthcare sector and 124.13% lower than that of the Diagnostics & Research industry. The net income for all Sweden stocks is 107.32% higher than that of the company.
Scibase Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Scibase AB's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Scibase AB could also be used in its relative valuation, which is a method of valuing Scibase AB by comparing valuation metrics of similar companies.Scibase AB is currently under evaluation in net income category among its peers.
Scibase Fundamentals
| Return On Equity | -0.9 | |||
| Return On Asset | -0.43 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.59) % | |||
| Current Valuation | 208.42 M | |||
| Shares Outstanding | 68.48 M | |||
| Shares Owned By Insiders | 26.42 % | |||
| Shares Owned By Institutions | 16.44 % | |||
| Price To Earning | (2.75) X | |||
| Price To Book | 7.00 X | |||
| Price To Sales | 16.25 X | |||
| Revenue | 11.73 M | |||
| Gross Profit | 11.23 M | |||
| EBITDA | (38.82 M) | |||
| Net Income | (41.78 M) | |||
| Cash And Equivalents | 65.61 M | |||
| Cash Per Share | 3.49 X | |||
| Total Debt | 356 K | |||
| Current Ratio | 5.72 X | |||
| Book Value Per Share | 0.37 X | |||
| Cash Flow From Operations | (39.5 M) | |||
| Earnings Per Share | (0.66) X | |||
| Target Price | 11.0 | |||
| Number Of Employees | 21 | |||
| Beta | 1.51 | |||
| Market Capitalization | 195.86 M | |||
| Total Asset | 85.46 M | |||
| Retained Earnings | (352 M) | |||
| Working Capital | 96 M | |||
| Current Asset | 106 M | |||
| Current Liabilities | 10 M | |||
| Net Asset | 85.46 M |
About Scibase AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Scibase AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scibase AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scibase AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.